Mega Lifesciences Public Company Limited (MEGA.BK)
THB 32.75
(0.0%)
THB 32.75
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.57 Billion THB | 6.56% |
| 2022 | 2.89 Billion THB | 22.14% |
| 2021 | 2.58 Billion THB | 27.57% |
| 2020 | 1.99 Billion THB | 21.11% |
| 2019 | 1.53 Billion THB | -0.43% |
| 2018 | 1.59 Billion THB | 3.99% |
| 2017 | 1.47 Billion THB | 29.63% |
| 2016 | 1.1 Billion THB | 38.12% |
| 2015 | 985.77 Million THB | 8.92% |
| 2014 | 785.69 Million THB | -7.1% |
| 2013 | 845.7 Million THB | 7.37% |
| 2012 | 798.28 Million THB | 19.63% |
| 2011 | 657.34 Million THB | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 751.61 Million THB | 2.15% |
| 2024 Q2 | 686.24 Million THB | 10.23% |
| 2023 Q3 | 799.02 Million THB | -7.75% |
| 2023 Q4 | 874.26 Million THB | 9.42% |
| 2023 FY | - THB | 6.56% |
| 2023 Q1 | 676.56 Million THB | 0.01% |
| 2023 Q2 | 866.14 Million THB | 28.02% |
| 2022 Q3 | 849.35 Million THB | 26.93% |
| 2022 Q1 | 798.74 Million THB | 34.43% |
| 2022 Q2 | 669.14 Million THB | -16.22% |
| 2022 Q4 | 676.51 Million THB | -20.35% |
| 2022 FY | - THB | 22.14% |
| 2021 Q2 | 629.76 Million THB | 26.51% |
| 2021 Q3 | 729.34 Million THB | 15.81% |
| 2021 Q4 | 594.15 Million THB | -18.54% |
| 2021 FY | - THB | 27.57% |
| 2021 Q1 | 497.78 Million THB | -20.35% |
| 2020 Q1 | 446.45 Million THB | -15.47% |
| 2020 FY | - THB | 21.11% |
| 2020 Q2 | 374.29 Million THB | -16.16% |
| 2020 Q3 | 475.61 Million THB | 27.07% |
| 2020 Q4 | 624.95 Million THB | 31.4% |
| 2019 Q4 | 528.17 Million THB | 35.97% |
| 2019 Q3 | 388.44 Million THB | 27.15% |
| 2019 FY | - THB | -0.43% |
| 2019 Q2 | 305.5 Million THB | -16.15% |
| 2019 Q1 | 364.34 Million THB | -28.35% |
| 2018 Q2 | 369.91 Million THB | -4.85% |
| 2018 FY | - THB | 3.99% |
| 2018 Q4 | 508.47 Million THB | 55.91% |
| 2018 Q3 | 326.13 Million THB | -11.84% |
| 2018 Q1 | 388.76 Million THB | -25.12% |
| 2017 FY | - THB | 29.63% |
| 2017 Q1 | 253.11 Million THB | -36.18% |
| 2017 Q2 | 380.31 Million THB | 50.26% |
| 2017 Q3 | 379.55 Million THB | -0.2% |
| 2017 Q4 | 519.18 Million THB | 36.79% |
| 2016 Q1 | 211.77 Million THB | -41.51% |
| 2016 Q2 | 320.06 Million THB | 51.13% |
| 2016 Q3 | 253.51 Million THB | -20.79% |
| 2016 Q4 | 396.61 Million THB | 56.45% |
| 2016 FY | - THB | 38.12% |
| 2015 Q2 | 201.01 Million THB | 9.37% |
| 2015 Q4 | 362.05 Million THB | 232.45% |
| 2015 Q3 | 108.9 Million THB | -45.82% |
| 2015 Q1 | 183.78 Million THB | -43.3% |
| 2015 FY | - THB | 8.92% |
| 2014 Q2 | 185.05 Million THB | 64.43% |
| 2014 FY | - THB | -7.1% |
| 2014 Q4 | 324.15 Million THB | 97.71% |
| 2014 Q3 | 163.95 Million THB | -11.4% |
| 2014 Q1 | 112.53 Million THB | -50.35% |
| 2013 Q4 | 226.64 Million THB | 3.75% |
| 2013 Q3 | 218.45 Million THB | -9.8% |
| 2013 Q1 | 158.41 Million THB | -24.16% |
| 2013 FY | - THB | 7.37% |
| 2013 Q2 | 242.18 Million THB | 52.88% |
| 2012 FY | - THB | 19.63% |
| 2012 Q2 | 153.37 Million THB | 0.0% |
| 2012 Q4 | 208.86 Million THB | 19.09% |
| 2012 Q3 | 175.38 Million THB | 14.35% |
| 2011 FY | - THB | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Mega Lifesciences Public Company Limited | 2.57 Billion THB | 0.0% |